Healthcare Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox

INDUSTRY
Healthcare

RELEASE DATE
24-Dec-2020
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D9D8-01-00-00-00
SKU
HC03374-NA-TR_25106
Yes
SHARE

Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care
Published on: 24-Dec-2020 | SKU: HC03374-NA-TR_25106

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their share of drawbacks including invasive profile and therapy-related complications, that have necessitated the development of novel neuromodulation methods that can provide effective relief from mental disorders for the patients, while at the same time are non-invasive, safe, and tolerable.
This growth opportunity-technology (GO-TE) report highlights the innovations in non-invasive neuromodulation technologies being implemented for treating mental health conditions, including transcranial electrical stimulation, transcranial magnetic stimulation, cranial electrotherapy stimulation and other therapies such as transcutaneous vagus nerve stimulation, trigeminal nerve stimulation, and multi-channel simultaneous stimulation.The scope of this GO-TE is global. This GO-TE studies some of the path breaking innovators in this space and their technology readiness levels. The report also discusses the funding, partnerships, and emerging growth opportunities.

1.1 Scope of the Research

1.2 Research Methodology

1.2 Research Methodology (continued)

2.1 Growing Burden of Mental Health Disorders Globally

2.2 Neuromodulation Techniques Address the Limitations of Drug-based and Psychotherapy Methods for Managing Mental Disorders

2.3 Drawbacks of Traditional Neuromodulation Methods are Hindering their Wide-spread Adoption

2.4 Technology Segmentation for Emerging Neuromodulation Therapies

2.5 Transcranial Electrical Stimulation Enabling Neuromodulation of Specific Cortical Regions of the Brain

2.6 Transcranial Magnetic Stimulation Facilitates Neuromodulation of Wide and Deeper Subcortical Structures in the Brain

2.7 Enabling Neuromodulation of Cortical and Subcortical Areas in the Brain through Cranial Electrotherapy Stimulation

2.8 Neuromodulation of Vagus, Occipital, and Trigeminal Nerve for Treating Mental Disorders

2.9 Application Analysis: Increasing Application Areas Offer Lucrative Growth Opportunities for Companies Developing Emerging Neuromodulation Technologies

2.10 Benchmarking Rubrics

2.11 Impact of TMS to be Relatively High as Compared to Other Emerging Neuromodulation Technologies

3.1 Transcranial Direct Current Stimulation System for Managing Depression

3.2 Other Notable Transcranial Direct Current Stimulation Systems for Treating Depression

3.3 Transcranial Magnetic Stimulation System for Managing Depression and Obsessive-compulsive Disorder

3.4 Other Notable Transcranial Magnetic Stimulation Systems for Depression Treatment

3.5 Over-ear Headphone-based Cranial Electrotherapy Stimulator Device for the Treatment of Anxiety, Depression, and Insomnia

3.6 Other Notable Cranial Electrotherapy Stimulation Systems for Treating Anxiety and Depression

3.7 External Trigeminal Nerve Stimulation System for Treating Attention-deficit/Hyperactivity Disorder in Patients

3.8 Other Notable Non-invasive Vagus Nerve Stimulation and Multi-channel Brain Neuromodulation Systems for Managing Mental Disorders

4.1 Analysis of National Institutes of Health (NIH) Funding for Emerging Neuromodulation Technologies

4.2 Funding Assessment for Emerging Neuromodulation Technologies

4.3 Partnerships between Mental Health Companies and Health Providers for Improving Access to Neuromodulation Therapies

4.4 Acquisitions by Mental Health Neuromodulation Participants for Improving Intellectual Property and Product Portfolio

5.1 Growth Opportunity: Emerging Neuromodulation Technology Innovations, 2020

5.2 Growth Opportunity 1: Distance Health Facilitated through Wearable-enabled Neuromodulation Therapies

5.3 Growth Opportunity 2: Incorporating Artificial Intelligence into Neuromodulation Systems for Providing Smart Therapy

5.4 Growth Opportunity 3: Partnerships between Non-invasive Neuromodulation Therapy Companies and Specialized Mental Health Providers to Improve Access to Underserved Populations

5.5 Patent Scenario-Key Patents for Transcranial Magnetic Stimulation Systems

5.6 Patent Scenario-Key Patents for Transcranial Electrical Stimulation and Trigeminal Nerve Stimulation Systems

6.1 Key Contacts

7.1 Your Next Steps

7.2 Why Frost, Why Now?

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

11 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their share of drawbacks including invasive profile and therapy-related complications, that have necessitated the development of novel neuromodulation methods that can provide effective relief from mental disorders for the patients, while at the same time are non-invasive, safe, and tolerable. This growth opportunity-technology (GO-TE) report highlights the innovations in non-invasive neuromodulation technologies being implemented for treating mental health conditions, including transcranial electrical stimulation, transcranial magnetic stimulation, cranial electrotherapy stimulation and other therapies such as transcutaneous vagus nerve stimulation, trigeminal nerve stimulation, and multi-channel simultaneous stimulation.The scope of this GO-TE is global. This GO-TE studies some of the path breaking innovators in this space and their technology readiness levels. The report also discusses the funding, partnerships, and emerging growth opportunities.
More Information
Deliverable Type Technology Research
No Index No
Podcast No
Author Neeraj Nitin Jadhav
Industries Healthcare
WIP Number D9D8-01-00-00-00
Is Prebook No

Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03374-NA-TR_25106